An Indiana House committee has approved a Republican-led bill that would fund clinical research trials into psilocybin that has already cleared the full Senate.
After adopting one amendment, the House Public Health Committee advanced the legislation in a 12-1 vote on Tuesday.
“This is not fringe science at this point, so my original intent was to elevate this potential,” Sen. Ed Charbonneau (R), the bill’s sponsor, told panel members ahead of the vote. “It creates hope for people that currently are in hopeless situations.”
“I think it’s important that we get clear right up front that this bill does not make anything legal that’s illegals today,” he said, highlighting the research-focused nature of the legislation.
Rep. Brad Barrett (R), who chairs the committee, said he was initially “incredibly skeptical” of psilocybin’s therapeutic potential but was moved by testimony he heard during an interim study session on the issue that lawmakers convened last year and “left there with the same kind of feeling” that Charbonneau expressed about the psychedelic’s ability to help people.
Last week, the Senate passed the psychedelics measure in a 47-1 vote. That followed the proposal being passed unanimously by the Senate Appropriations Committee and the Health and
Read full article on Marijuana Moment
